https://biotechdispatch.com.au/news/invion-updates-on-phase-2-prostate-cancer-trial-of-inv043?utm_source=AusBiotech&utm_campaign=e5d8fb3ba8-15_February_20132_15_2013_COPY_03&utm_medium=email&utm_term=0_7edf30a86c-e5d8fb3ba8-126992042
- Forums
- ASX - By Stock
- IVX
- News posted on Linkedin
News posted on Linkedin
Featured News
Add IVX (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.63M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $7.436K | 3.718M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
31 | 19611781 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 8426664 | 45 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
31 | 19611781 | 0.002 |
28 | 40674325 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 8426664 | 45 |
0.004 | 12138036 | 15 |
0.005 | 5373292 | 19 |
0.006 | 1338326 | 4 |
0.007 | 1567119 | 3 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
IVX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online